Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma

Nivolumab plus ipilimumab combination is currently one of the preferred regimens for advanced melanoma in recently updated clinical practice guidelines. However, the evidence on the efficacy of the combination for acral or mucosal subtypes remains less robust. This is the final analysis of a multice...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Dermatol
Huvudupphovsmän: Namikawa, Kenjiro, Kiyohara, Yoshio, Takenouchi, Tatsuya, Uhara, Hisashi, Uchi, Hiroshi, Yoshikawa, Shusuke, Takatsuka, Sumiko, Koga, Hiroshi, Wada, Naoko, Minami, Hironobu, Hatsumichi, Masahiro, Namba, Yoshinobu, Yamazaki, Naoya
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693067/
https://ncbi.nlm.nih.gov/pubmed/32812243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.15514
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk